Document is current
Any future updates will be listed below
-
Authors
Chin, Pei-Ju
Tsou, Jen-Hui
Armstrong, Alison
Deneyer, Noémie
Zanda, Valeria
Ayama-Canden, Sophie
Colinet, Anne-Sophie
Fuentes, Sandra M.
Korokhov, Nikolay
Lambert, Christophe
Lavorgna, Alfonso
Noll, Manuel
Olgiati, Simone
Protz, Michel
Shaid, Shahjahan
Sohrabi, Afshin
Whiteman, Mary
Khan, Arifa S.
-
Funding
Funding for this research was provided by:
National Institute for Innovation in Manufacturing Biopharmaceuticals/Gates Foundation (OPP1204996)
National Institute for Innovation in Manufacturing Biopharmaceuticals/Gates Foundation (OPP1204996)
National Institute for Innovation in Manufacturing Biopharmaceuticals/Gates Foundation (OPP1204996)
National Institute for Innovation in Manufacturing Biopharmaceuticals/Gates Foundation (OPP1204996)
- License Information
-
More Information
Article History
Received: 23 May 2025
Accepted: 9 December 2025
First Online: 23 December 2025
Competing interests
: C.L., M.P., A-S.C., S.S. and N.D. are employees of the GSK group of companies and may hold shares in GSK; A.A., A.S., N.K., A.L., and M.W. are employees of the MilliporeSigma organization and may hold shares in MilliporeSigma. V.Z. and S.O. are employees of EMD Serono RBM S.p.A, and affiliate of Merck KGaA, Darmstadt, Germany, and may hold shared in Merck KGaA. All other authors declare no competing interests.
